


To provide long-term capital growth through investment primarily in a growth style biased portfolio of UK companies.
| Name | % Net Assets |
|---|---|
| Royal Dutch Shell | 8.9% |
| BP | 7.9% |
| Vodafone | 5.8% |
| GlaxoSmithKline | 4.9% |
| BG | 3.3% |
| AstraZeneca | 3.2% |
| British American Tobacco | 3.0% |
| Tesco | 2.5% |
| Diageo | 2.0% |
| Reckitt Benckiser | 1.8% |
| Key | % Net Assets |
|---|---|
| 8.9% | |
| 7.9% | |
| 5.8% | |
| 4.9% | |
| 72.5% |
| Date | 09-Sep-2022 |
|---|---|
| NAV | 127.10p |
| Currency | GBP |
| Change | 2.10p |
| % | 1.68% |
| YTD change | 127.10p |
| YTD % | n/a |
| Fund Inception | 18/12/2008 |
|---|---|
| Fund Manager | n/a |
| TER | 1.68 (31-Jan-2013) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £100 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research